8 结果
FIELD OF THE INVENTION
The present invention concerns lipid-based compositions and use of such compositions in the treatment of withdrawal syndromes or cancer.
BACKGROUND OF THE INVENTION AND PRIOR ART
Withdrawal syndromes can occur during rehabilitation from addiction to drugs, alcohol, cigarettes
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Phase under 35 U.S.C. .sctn.371 of International Application PCT/CL2012/000005, filed Feb. 6, 2012, which was published in a non-English language, which claims priority to CL Patent Application no. 0273-2011, filed Feb. 8,
FIELD OF INVENTION
This invention relates to methods and compositions for the diagnosis, classification, and treatment of cancer. More specifically, this invention is a method of identifying cancer using novel protein phosphorylation status.
BACKGROUND OF THE INVENTION
The intracellular tyrosine
TECHNICAL FIELD
The present invention relates to a carba cyclic phosphatidic acid derivative, and a medicament using the same.
BACKGROUND ART
Lysophosphatidic acid (LPA) has the simplest structure among phospholipids which compose the biological membrane, wherein either fatty acid at the sn-1 or -2
BACKGROUND
Phosphatidic acid (PA) is a cofactor required for the full activation of several signaling pathways prominent in cancer cells; among these are Raf family members, PKC-.zeta., SOS and mTOR. (Bonham et al., Lysophosphatidic acid acyltransferase-beta: a novel target for induction of tumour
TECHNICAL FIELD OF THE INVENTION
The present invention provides a method for treating diseases mediated by cellular proliferation in response to platelet derived growth factor (PDGF), fibroblast derived growth factor (FGF), epidermal derived growth factor (EGF) and vascular endothelial growth factor
TECHNICAL FIELD OF THE INVENTION
The present invention provides a method for treating diseases mediated by cellular proliferation in response to platelet derived growth factor (PDGF), fibroblast derived growth factor (FGF), epidermal derived growth factor (EGF) and vascular endothelial growth factor
TECHNICAL FIELD OF THE INVENTION
The present invention provides a method for treating diseases mediated by cellular proliferation in response to platelet derived growth factor (PDGF), fibroblast derived growth factor (FGF), epidermal derived growth factor (EGF) and vascular endothelial growth factor